Glenmede Trust CO Na Chemo Centryx, Inc. Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$9.59 - $50.88 $46,089 - $244,529	-4,806 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$49.53 - $68.4 $2,922 - $4,035	59 Added 1.24%	4,806 $246,000
Q4 2020 Feb 16, 2021	BUY	$47.25 - $65.16 $105,131 - $144,981	2,225 Added 88.22%	4,747 $293,000
Q3 2020 Nov 16, 2020	BUY	$46.35 - $61.69 $115,179 - $153,299	2,485 Added 6716.22%	2,522 $138,000
Q2 2020 Aug 14, 2020	BUY	$38.58 - $65.07 $1,427 - $2,407	37 New	37 $2,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.